Literature DB >> 31736417

Brain microvascular pathology in Susac syndrome: an electron microscopic study of five cases.

Dimitri P Agamanolis1, Richard A Prayson2, Negar Asdaghi3, Sakir H Gultekin4, Kim Bigley5, Robert M Rennebohm6.   

Abstract

Susac syndrome is a rare, immune-mediated disease characterized by encephalopathy, branch retinal artery occlusion, and hearing loss. Herein, we describe the electron microscopic findings of three brain biopsies and two brain autopsies performed on five patients whose working clinical diagnosis was Susac syndrome. In all five cases, the key findings were basement membrane thickening and collagen deposition in the perivascular space involving small vessels and leading to thickening of vessel walls, narrowing, and vascular occlusion. These findings indicate that Susac syndrome is a microvascular disease. Mononuclear cells were present in the perivascular space, underlining the inflammatory nature of the pathology. Though nonspecific, the changes can be distinguished from genetic and acquired small vessel diseases. The encephalopathy of Susac syndrome overlaps clinically with degenerative and infectious conditions, and brain biopsy may be used for its diagnosis. Its vascular etiology may not be obvious on light microscopy, and electron microscopy is important for its confirmation.

Entities:  

Keywords:  Susac syndrome; branch retinal artery occlusion; cerebral vasculitis; corpus callosal lesions; electron microscopy; encephalopathy; hearing loss

Year:  2019        PMID: 31736417     DOI: 10.1080/01913123.2019.1692117

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  4 in total

1.  Imaging Features of Susac Syndrome on High-Resolution Intracranial Vessel Wall MRI.

Authors:  Noushin Yahyavi-Firouz-Abadi; Matthew Kiczek; Steven R Zeiler; Bruce A Wasserman
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-04-16

Review 2.  Fundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases.

Authors:  Heinz Wiendl; Catharina C Gross; Jan Bauer; Doron Merkler; Alexandre Prat; Roland Liblau
Journal:  Nat Rev Neurol       Date:  2021-05-28       Impact factor: 42.937

3.  Good therapeutic response to infliximab in a case of Susac syndrome refractory to immunotherapies including tocilizumab.

Authors:  Stanislas Demuth; Thomas Bogdan; Laurent Kremer; Livia Lanotte; Nicolas Collongues; Jérôme de Seze; Kévin Bigaut
Journal:  J Neurol       Date:  2022-01-19       Impact factor: 6.682

4.  Quantitative MRI findings indicate diffuse white matter damage in Susac Syndrome.

Authors:  P Johnson; J K Chan; I M Vavasour; S Abel; L E Lee; H Yong; C Laule; Dkb Li; R Tam; A Traboulsee; R L Carruthers; S H Kolind
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-02-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.